Yervoy

Ipilimumab, sold under the brand name Yervoy, is an intravenous immunotherapy used to treat certain cancers by helping the immune system recognize and attack tumor cells. It belongs to the class of checkpoint inhibitors and is administered in clinical settings. This medication is prescribed for specific oncology indications under professional supervision.

Ipilimumab is used to treat melanoma, a serious form of skin cancer, and may be prescribed for other cancers as determined by healthcare providers. It works by blocking a protein called CTLA-4, which helps immune cells identify and destroy cancer cells more effectively. This immunotherapy is typically used when cancer has spread or cannot be removed by surgery.

Patients receiving ipilimumab may experience immune-related effects as the body’s immune system becomes more active. Common effects can include fatigue, skin reactions, or gastrointestinal symptoms. These effects vary by individual and should be monitored by a healthcare professional throughout treatment.

This medication should only be handled and administered by trained medical personnel in a clinical setting. Patients must be monitored for signs of immune-related side effects, such as inflammation of organs or tissues. It is important to disclose all current medications and health conditions to the prescribing doctor before starting treatment.

Ipilimumab may interact with other medications that affect the immune system, such as corticosteroids or other immunotherapies. Combining it with certain chemotherapy drugs or biologics could impact effectiveness or increase side effects. Patients should inform their healthcare provider about all prescription, over-the-counter, and herbal products they are using.